Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-9-16
pubmed:abstractText
Pathologic angiogenesis in the retina leads to the catastrophic loss of vision. Retinopathy of prematurity (ROP), a vasoproliferative retinopathy, is a leading cause of blindness in children. We evaluated the inhibitory effect of decursin on retinal neovascularization.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-10327068, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-11283670, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-11387210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-12778166, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-12877552, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-14560921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-14692684, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-15769635, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-16355161, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-16409133, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17038532, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17332988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17565155, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17637179, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17803958, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-17919602, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-18208562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-19228635, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-19718802, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-2388790, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-5706829, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-7479819, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-7507904, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-7526212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-8643492, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-8720379, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-8843598, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-9034784, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756180-9109485
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1090-0535
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1868-75
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.
pubmed:affiliation
Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Department of Ophthalmology, College of Medicine, Seoul National University and Seoul Artificial Eye Center Clinical Research Institute, Seoul National University Hospital, Seoul 151-744, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't